Treatment of rheumatoid arthritis with biologic and targeted synthetic disease-modifying anti-rheumatic drugs in 2022 – real-world data from the Romanian Registry of Rheumatic Diseases

Treatment of rheumatoid arthritis with biologic and targeted synthetic disease-modifying anti-rheumatic drugs in 2022 – real-world data from the Romanian Registry of Rheumatic Diseases

Objective. The study aimed at characterizing the evolution of RA treatment with b/tsDMARDs in Romania, since the end of the SARS-CoV-2 pandemic and the national approval of JAKi. Methods. Data on RA patients was obtained from the Romanian Registry of Rheumatic Diseases database between January 1st,...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Elena Rezus, Claudiu C. Popescu, Corina Mogosan, Claudiu Avram, Razvan-Constantin Ionitescu, Ioana Felea, Ileana-Cosmina Filipescu, Catalin Codreanu
Materialtyp: Artikel
Språk:English
Publicerad: Amaltea Medical Publishing House 2023-09-01
Serie:Romanian Journal of Rheumatology
Ämnen:
rheumatoid arthritis
romanian registry of rheumatic diseases
biologic treatment
Länkar:https://rjr.com.ro/articles/2023.3/RJR_2023_3_Art-07.pdf

Liknande verk

Liknande verk